🏭 Our Expansion Journey

We are proud to announce a major step forward in our manufacturing capabilities, reinforcing our commitment to quality, compliance, and innovation.

πŸ“… May 2026 – Strategic Planning

Exploring lease or purchase options for a dedicated manufacturing facility.

πŸ—οΈ June 2026 – cGMP Facility Setup

A 2,150 sq. ft. cGMP-compliant facility within a 10,000 sq. ft. industrial manufacturing setup including:

  • Sampling booths
  • In-process testing laboratory
  • Dispensing booths
  • Solid dosage form or Tablet manufacturing
    • Mixing and sieving
    • Dry granulation, moist heat granulation, and drying
    • Tablet Compression, and Coating
    • Solid dosage form or Tablet manufacturing
  • Finish product testing laboratory
  • Stability study area

βœ… July–August 2026 – Inspection & Approval

FDA or third-party inspection for cGMP compliance and approval.